Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies.

CONCLUSION: Brachytherapy is a highly effective and relatively safe treatment option therefore its underuse is no longer justified. Further studies should investigate the optimal radiation dose and number of fractions able to achieve the highest DFS rates. PMID: 28104297 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28104297?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - January 15, 2017 Category: Radiology Authors: Fuccio L, Mandolesi D, Farioli A, Hassan C, Frazzoni L, Guido A, de Bortoli N, Cilla S, Pierantoni C, Violante FS, Bazzoli F, Repici A, Morganti AG Tags: Radiother Oncol Source Type: research